Teva And Apotex Fail To Bar Sun And Sandoz From Canadian Rivaroxaban Case
• By Aidan Fry
Four generic defendants will now take part in a claim construction and invalidity hearing over Canadian patents protecting Bayer's Xarelto brand • Source: Shutterstock
